Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Notes Payables (2024 - 2025)

Orthopediatrics (KIDS) has disclosed Notes Payables for 2 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Notes Payables rose 73.08% to $2.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.5 million, a 73.08% increase, with the full-year FY2025 number at $2.5 million, up 73.08% from a year prior.
  • Notes Payables was $2.5 million for Q4 2025 at Orthopediatrics, up from $1.3 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $2.5 million in Q4 2025 to a low of $1.3 million in Q3 2025.